ICMR transfers medical technologies under Patent Mitra Initiative NEW DELHI: A potential new treatment for cervical pre-cancer and two next-generation vaccines against typhoid and other gut infections have moved a step closer to becoming available in India after the Indian Council of Medical Research (ICMR) licensed the technologies to Indian pharmaceutical companies. If successful, the indigenous products could improve access to affordable treatment and vaccines while reducing dependence on imported technologies.The technologies have been transferred under ICMR’s Medical Innovations Patent Mitra initiative, which helps convert government-funded research into products that can be developed, tested and eventually brought to the market.Among them is SHetA2, a potential treatment for Cervical Intraepithelial Neoplasia (CIN), a precancerous condition caused by persistent infection with the human papillomavirus (HPV). If left untreated, CIN can progress to cervical cancer, one of the leading cancers among Indian women.Unlike surgery, which is commonly used to remove abnormal cells, SHetA2 is designed to selectively destroy HPV-infected abnormal cells while sparing healthy cells. Scientists believe it could offer women a safer and less invasive treatment option in the future. The technology has been licensed to Emcure Pharmaceuticals for further development, clinical testing and commercialisation.ICMR has also licensed two vaccine technologies developed by its National Institute for Research in Bacterial Infections (NIRBI), Kolkata, to Biological E. One is a next-generation vaccine against typhoid, while the other is designed to protect against typhoid, paratyphoid and Shigella, bacteria that cause severe diarrhoea and other intestinal infections, particularly among children.The vaccine candidates will now undergo further development and evaluation before they can be considered for regulatory approval and public use.Dr Rajiv Bahl, Secretary, Department of Health Research, and Director General, ICMR, said partnerships between researchers and industry are helping move promising discoveries from laboratories to patients while strengthening India’s biomedical innovation ecosystem.The technology transfer is part of ICMR’s broader effort to support indigenous healthcare innovation through patent protection, technology licensing, clinical validation and regulatory facilitation, with the aim of making affordable medicines and vaccines available to patients.Get the latest India News and Live updates. Download the TOI app.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosIndia Rejects Pakistan’s Flood Allegation, Says Chenab Surge Caused By Heavy Monsoon Rainfall AloneDelhi Police Flags 400 People With Criminal Records Near CJP Protest Using Facial Recognition SystemCJP To Collect Protest Videos, Identify Police Personnel, Seek FIRs Over July 20 CrackdownCabinet Approves Tougher Anti-Paper Leak Bill; Up To 10-Year Jail And Rs 10 Crore Fine ProposedDelhi Police Fact-Checks Viral Claim On Passport Cancellation Of CJP ProtestersCentre Seeks Time Till Saturday On Dharmendra Pradhan’s Resignation Demand, Says CJP After TalksMassive Anti-Terror Sweep After Anantnag Terror Attack, Omar Abdullah Questions ActionUS Slaps 10% Tariff on India! Is This a Trade Warning or a Big Win for Indian Exports?Delhi Police Special Cell Probe Into Violence Against 129 Personnel, 11 FIRs Registered | WatchSonam Wangchuk Ends Fast After Centre’s Written Assurances As Delhi Remains Under Lockdown Measures123PhotostoriesFrom black rice to basmati: Indian rice varieties ranked from most to least nutritiousMeet the cast of ’72 Hours,’ led by Kevin Hart, Mason Gooding and Marcello HernándezHeart disease in women: Women with THIS common hormonal condition are at higher risk, new study findsKyunki Saas Bhi Kabhi Bahu Thi’s Apara Mehta on separation with husband; recalls husband Darshan Jariwala saying, ‘I’ve Fallen Out of Love, You’re the Ugliest Woman’What happens when you mix bay leaves and vinegar and use it in the kitchen?Why Indian women wear toe rings: The forgotten meanings across different statesShubhanshu Shukla carried 3 Indian dishes to space: 9 other desi dishes that made to space in pastFeeling emotionally drained? These 5 things may be weighing you downDia Mirza’s ivory anarkali is so graceful, it leaves maximalism searching for attention10 beautiful baby names inspired by timeless musical instruments123Hot PicksSchool holiday todayDelhi metroCJP ProtestMumbai rainGujarat RainAIIMS notificationNEET paper controversyAAI recruitment 2026Caitline ClarkTop TrendingMP NEET Arpirant RapeNEET Paper LeakCJP Protester AssaultedKerala IPS Ajith Kumar SuspensionAssam Flood DeathsDelhi Metro Stations ClosedMumbai ProtestUP Amroha WeddingHarbhajan singhIND U19 vs Sri Lanka U19
ICMR transfers medical technologies under Patent Mitra Initiative NEW DELHI: A potential new treatment for cervical pre-cancer and two next-generation vaccines against typhoid and other gut infections have moved a step closer to becoming available in India after the Indian Council of Medical Research (ICMR) licensed the technologies to Indian pharmaceutical companies. If successful, the…
